Comparison of intraocular pressure lowering by topical and systemic carbonic anhydrase inhibitors in the rabbit

被引:10
作者
Fanous, MM [1 ]
Challa, P [1 ]
Maren, TH [1 ]
机构
[1] Eye & Ear Inst Pittsburgh, Pittsburgh, PA 15213 USA
关键词
D O I
10.1089/jop.1999.15.51
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
We compared the effect on intraocular pressure (IOP) of maximal doses of a topical carbonic anhydrase inhibitor (CAI) at acidic and alkaline pH where it is maximally effective with full systemic CA inhibition in ocular normotensive New Zealand Albino rabbits. Tonometric IOP levels were measured hourly during 3 hour control period. Topical MK-417 (pKa 5.8, 8.3), a close congener of MK-507 (Dorzolamide) was given as a 1.4% solution at pH 4.5 (n=6) and pH 9.2 (n=6). MK-417 was instilled to the left eye with the right eye used as an untreated control. One hour later methazolamide was given intravenously at 10 mg/kg, a dose known to give full inhibition of the enzyme. Control IOP (mm Hg) was 19.12 +/- 0.50. One hour following MK-417, the left eye IOP was 13.40 +/- 0.70 (pH 4.5) and 13.25 +/- 0.70 (pH 9.2). The right eye pressure was unchanged. Methazolamide injection at this time gave no further drop in the left eye IOP at either pH. IOP in the right eye fell to 14.00 +/- 0.70 so that 2 hours after methazolamide injection, the 2 eyes had the same pressure. In conclusion topical CAI in sufficient dose and correct pH yields IOP lowering equivalent to a maximally effective dose of systemic CAI in rabbits.
引用
收藏
页码:51 / 57
页数:7
相关论文
共 18 条
[11]   RELATIONS AMONG IOP REDUCTION, OCULAR DISPOSITION AND PHARMACOLOGY OF THE CARBONIC-ANHYDRASE INHIBITOR ETHOXZOLAMIDE [J].
MAREN, TH ;
BRECHUE, WF ;
BARILAN, A .
EXPERIMENTAL EYE RESEARCH, 1992, 55 (01) :73-79
[12]   THE TRANSCORNEAL PERMEABILITY OF SULFONAMIDE CARBONIC-ANHYDRASE INHIBITORS AND THEIR EFFECT ON AQUEOUS-HUMOR SECRETION [J].
MAREN, TH ;
JANKOWSKA, L ;
SANYAL, G ;
EDELHAUSER, HF .
EXPERIMENTAL EYE RESEARCH, 1983, 36 (04) :457-479
[13]   Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans [J].
Maus, TL ;
Larsson, LI ;
McLaren, JW ;
Brubaker, RF .
ARCHIVES OF OPHTHALMOLOGY, 1997, 115 (01) :45-49
[14]   A SINGLE DOSE OF THE TOPICAL CARBONIC-ANHYDRASE INHIBITOR MK-927 DECREASES IOP IN PATIENTS [J].
PFEIFFER, N ;
HENNEKES, R ;
LIPPA, EA ;
GREHN, F ;
GARUS, H ;
BRUNNERFERBER, FL .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1990, 74 (07) :405-408
[15]  
RIDDERSTRALE Y, 1994, INVEST OPHTH VIS SCI, V35, P2577
[16]   MK-927 - A TOPICALLY ACTIVE OCULAR HYPOTENSIVE CARBONIC-ANHYDRASE INHIBITOR [J].
SUGRUE, MF ;
GAUTHERON, P ;
GROVE, J ;
MALLORGA, P ;
VIADER, MP ;
SCHWAM, H ;
BALDWIN, JJ ;
CHRISTY, ME ;
PONTICELLO, GS .
JOURNAL OF OCULAR PHARMACOLOGY, 1990, 6 (01) :9-22
[17]   L-662,583 IS A TOPICALLY EFFECTIVE OCULAR HYPOTENSIVE CARBONIC-ANHYDRASE INHIBITOR IN EXPERIMENTAL-ANIMALS [J].
SUGRUE, MF ;
GAUTHERON, P ;
MALLORGA, P ;
NOLAN, TE ;
GRAHAM, SL ;
SCHWAM, H ;
SHEPARD, KL ;
SMITH, RL .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (01) :59-64
[18]  
WISTRAND PJ, 1992, INT C EY RES STRES I